Clinical trials in North Macedonia
141 studies list at least one site in North Macedonia. 22 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-06.
Get an email when these change. Save the studies in North Macedonia recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Novo Nordisk A/S (11) · Hoffmann-La Roche (10) · BioCryst Pharmaceuticals (5) · Chiesi Farmaceutici S.p.A. (4) · KalVista Pharmaceuticals, Ltd. (4) · Janssen Research & Development, LLC (4) · Teva Branded Pharmaceutical Products R&D, Inc. (3) · Ss. Cyril and Methodius University of Skopje (3)
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
- NIRAF-Guided Parathyroid Identification During ThyroidectomyNov 6, 2026NCT07617584
Stopped2
- Device Validation of Augmented-Reality ICG Fluorescence Imaging for Sentinel Lymph Node Detection in Breast CancerWithdrawnNov 5, 2026NCT07683572
- A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell CarcinomaTerminatedOct 20, 2026NCT05888844
Newly registered2
Studies
Recruiting first, then most recently updated. Showing 50 of 141 — search for more.
- Augmented-Reality ICG Fluorescence Second-Look for Residual Nodal Disease After Axillary Dissection in Breast CancerNot yet recruitingNCT07696754Not applicable
- NIRAF-Guided Parathyroid Identification During ThyroidectomyRecruitingNCT07617584Not applicable
- A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)RecruitingNCT07503873Phase 2
- A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)RecruitingNCT06858579Phase 3
- Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaNot yet recruitingNCT07885891Phase 3
- A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary FibrosisRecruitingNCT07516951Phase 2
- Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasERecruitingNCT07874139
- Computerized Registry of Patients With Venous Thromboembolism (RIETE)RecruitingNCT02832245
- A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaEnrolling by invitationNCT07204938Phase 3
- Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving OpioidsRecruitingNCT05588323Phase 1/2
- Randomized Controlled Trial of a Family-focused Intervention for Caregivers and Young Adolescents (Phase 3 of FLOURISH)RecruitingNCT07240571Not applicable
- Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis StudyRecruitingNCT05935358Phase 4
- Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenRecruitingNCT04124120Not applicable
- One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip FracturesRecruitingNCT07432737Not applicable
- Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i RegistryRecruitingNCT06932081
- Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat StudiesEnrolling by invitationNCT04933721Phase 3
- Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).RecruitingNCT06736288Phase 4
- Detection and Prevention of Cancer-Related Cardiovascular Toxicity RegistryRecruitingNCT06086132
- The C-MIC-II Follow-Up StudyRecruitingNCT05189860Not applicable
- Advancing Knowledge in Ischemic Stroke Patients on Oral AnticoagulantsRecruitingNCT06823466
- Caudal Anesthesia Versus Local Anesthesia in HypospadiasRecruitingNCT06417060Not applicable
- Intraoperative Imaging of Lymph NodesRecruitingNCT06276439
- Device Validation of Augmented-Reality ICG Fluorescence Imaging for Sentinel Lymph Node Detection in Breast CancerWithdrawnNCT07683572
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's DiseaseActive, not recruitingNCT03466411Phase 2/3
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)Active, not recruitingNCT07211633Phase 3
- A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell CarcinomaTerminatedNCT05888844Phase 2
- Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma PatientsCompletedNCT06551064Phase 1
- A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)Active, not recruitingNCT04961996Phase 3
- A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerActive, not recruitingNCT03456076Phase 3
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationTerminatedNCT05636176Phase 3
- Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisActive, not recruitingNCT05134441Phase 3
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Active, not recruitingNCT04586010Phase 3
- A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsActive, not recruitingNCT05135559Phase 3
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple SclerosisActive, not recruitingNCT04544449Phase 3
- A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent StudiesActive, not recruitingNCT00781612Phase 2
- A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 DiabetesCompletedNCT04596631Phase 3
- A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyActive, not recruitingNCT06537999Phase 2
- A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)Active, not recruitingNCT06282159Phase 2
- D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)CompletedNCT04411199Phase 3
- A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III MelanomaCompletedNCT06153238Phase 1
- A Study of Milvexian in Participants After a Recent Acute Coronary SyndromeCompletedNCT05754957Phase 3
- A Study of Navenibart in Participants With Hereditary AngioedemaActive, not recruitingNCT06842823Phase 3
- An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)CompletedNCT05505916Phase 3
- Family-Focused Adolescent &Amp; Lifelong Health Promotion Optimization TrialCompletedNCT06562244Not applicable
- Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple SclerosisActive, not recruitingNCT06847724Phase 3
- A Study of DS-7011a in Patients With Systemic Lupus ErythematosusCompletedNCT05638802Phase 1/2
- GEN3014 Trial in Relapsed or Refractory Hematologic MalignanciesTerminatedNCT04824794Phase 1/2
- CIRSE Emprint Microwave Ablation RegistryCompletedNCT03775980
- A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or IITerminatedNCT05055258Phase 2
- Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of AgeCompletedNCT04953884Phase 3